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ABSTRACT
Purpose: To analyze the action of gangliosides in peripheral nerve regeneration in the sciatic nerve of the rat. Methods: The
sample was composed of 96 male Wistar rats. The animals were anaesthetized and, after identification of the anaesthesic plane, an
incision was made in the posterior region of the thigh, followed by skin and muscle divulsion. The right sciatic nerve was isolated
and compressed for 2 minutes. Continuous suture of the skin was performed. The animals were randomly divided into two
groups: the experimental group (EG), which received subcutaneous injection of gangliosides, and the control group (CG), which
received saline solution (0.9%) to mimic the effects of drug administration. Results: No differences were observed between the
experimental and control groups evaluated on the eighth day of observation. At 15 and 30 days the EG showed an decrease in
Schwann cell activity and an apparent improvement in fibre organization; at 60 days, there was a slight presence of Schwann cells
in the endoneural space and the fibres were organized, indicating nerve regeneration. At 15 and 30 days, the level of cell reaction
in the CG had diminished, but there were many cells with cytoplasm in activity and in mitosis; at 60 days, hyperplastic Schwann
cells and mitotic activity were again observed, as well as nerve regeneration, but to a lesser extent than in the EG. Conclusion:
The administration of exogenous gangliosides seems to improve nerve regeneration.
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RESUMO
Objetivo: Avaliar os efeitos de gangliosídeos na regeneração nervosa periférica em nervo isquiático de ratos após axonotmese.
Métodos: Foram utilizados 96 ratos machos albinos (Wistar). Os animais foram anestesiados e após constatação do plano anestésico,
foi realizada incisão na face posterior da coxa direita do animal. Em seguida, foi realizada a dissecção cirúrgica da pele e do
músculo e divulsão dos músculos. O nervo isquiático direito foi isolado e sofreu compressão por 2 minutos. Efetuou-se a sutura
contínua da pele. Os animais foram distribuídos aleatoriamente em 2 grupos: experimental (GE) que receberam gangliosídeos
pela via sub-cutânea e controle (GC) que receberam soro fisiológico 0,9% com a finalidade de mimetizar os efeitos de administração
da droga de estudo. A análise histopatológica foi realizada em 8, 15, 30 e 60 dias. Resultados: Não se evidenciaram diferenças
significantes entre os grupos controle e experimental avaliados com 8 dias. Nos grupos experimentais de 15 e 30 dias observou-
se uma diminuição da atividade das células de Schwann e aparente melhora na organização das fibras nervosas; com 60 dias havia
discreta presença células de Schwann no espaço endoneural e as fibras nervosas estavam organizadas sinalizando a regeneração
nervosa. Nos grupos controles de 15 e 30 dias o padrão de reação celular diminuiu, entretanto havia muitas células com citoplasmas
em atividade e mistose; com 60 dias observou-se ainda a presença de hiperplasia de células de Schwann, atividade mitótica ainda
presente e regeneração nervosa presente, porém em menor grau comparando-se com aquele visto no grupo experimental. Conclusão:
A administração de gangliosídeos exógenos parece incrementar a regeneração nervosa.
Descritores: Gangliosídeos. Regeneração Nervosa. Nervo Isquiático. Ratos.
1 Research performed at Department of Oral and Maxillofacial Surgery, FOP, Department of Morphological Sciences, ICB, UFPE and Depart-
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Introduction
Peripheral nerve damage is the most common surgical
and traumatic complication in human beings or animals. Such
damage may be caused by traumatic, neoplastic or iatrogenic
agents. The consequences of a nerve fibre injury depend on its
nature, site and intensity1.
Crushed nerve injury deliberately induced by compres-
sion (axonotmesis) is a good methodological design for research
on nerve regeneration. Since there is preservation of the crushed
nerve, the axons use their own endoneural tubes to migrate to-
wards the distal fragment, thereby enhancing regeneration with
little intervention by extraneous factors. The basal laminae of
the endoneural tubes resist the trauma, but some of the tubes
may rupture, exposing their content, with consequent loss of
material and functional alterations. Animal experiments repre-
sent  quite an important study model as a basis for nerve regen-
eration, and the sciatic nerve of the rat is the established experi-
mental model in the investigation of peripheral nerve regenera-
tion2,3,4,5,6,7,8,9. The choice of this experimental model was fur-
ther justified by the fact that the sciatic nerve of a rat has a large
diameter and is relatively easy to access10,11,12,13.
Axonotmesis is characterized by blocked nerve con-
duction and takes place in two phases: the first involves disin-
tegration of the axon and the breakage of the myelin sheath
(axonal or Wallerian degeneration) with disruption of the
axoplasmatic flow and distal nerve conduction. The second
phase, in response to the lesion, is the regeneration process of
the segment between the axon and its terminal organ, which is
influenced by the condition of the endoneuro. This type of le-
sion may be caused by heavy bruising, compression of the nerve,
or even an excessive stretching, manifesting itself in a com-
plete sensory motor paralysis. Functional nerve repair begins
from two to six weeks after surgery9,14. Nerve regeneration takes
place from the point where the damage was caused, so that the
axons proliferate towards the effector organ15, taking as their
guide the Hanken-Bunger bands, composed of Schwann cells.
When there is the preservation of the endoneural tubes, the
growth cone may easily reach the target organ. However, com-
plete sections not treated with the aid of sutures and located far
from the target organ tend to get lost on the way16.
Compression of peripheral nerves (axonotmesis) may
result in neuropathic pain or the sensory deficit syndrome. The
acute response is expressed by edema and inflammation. In the
first stage blood changes occur in the nerve barrier, resulting in
subperineural or endoneural edema. This induces changes in
the nerve’s connective tissue with a resultant widening of the
perineuro and endoneuro, followed by changes originating in
the nerve fibre (demyelination). Wallerian degeneration then
becomes apparent. The response to injury is inflammation of
the nerve, confirmed by the occurrence of neuroinflammatory
events, represented by endoneural infiltration of granulocytes
and immune cells (CD-4, CD-8 and T lymphocytes) at the site
of the nerve injury17.
Regeneration takes place at a defined pace, and the
signs of its occurrence may be expected from the time of the
trauma. The time required for axonal regeneration involves a
number of considerations including the following: a) it takes
approximately two weeks for the regenerating axons to reach
the distal nerve at the site of the lesion or suture; b) once on the
distal segment, regenerating axons grow at a rate of 1 mm a
day; c) there is a further period of weeks or months from the
arrival of the nerve fibres at their targets to the maturation of
the axons and their receptors, when maximum function is fi-
nally achieved17.
The development of drugs with neuropathic and neu-
rotrophic characteristics that mimic the neuronal growth factor
represents a landmark in the drug treatment of nerve injury, for
such nerve growth factors present in embryogenesis steer nerve
growth in the direction of the target organs18.
There are reports in the literature of the use of exog-
enous substances (gangliosides) to enhance peripheral nerve
regeneration in the lower animals8,9,18,19,20,21. Such substances are
involved in the process of development, differentiation and nerve
regeneration22.
In view of the above, the aim of this paper was to evalu-
ate, by means of histopathologic analysis, the effect of exog-
enous gangliosides on nerve regeneration in the sciatic nerve
of rats submitted to axonotmesis.
Methods
This was an experimental laboratory study in which
96 young adult male albino mice were used (Rattus norvegicus
of the Muridae family, Wistar laboratory variety), aged 3 months
and body weight ranging from 250 to 350 g at the time of sur-
gery, obtained from the animal colony of the Federal Rural Uni-
versity of  Pernambuco (UFRPE). The animals were submitted
to a quarantine period and confinement for adaptation to the
experimental conditions, when they were germ-freed against
endo- and ectoparasites (Mebendazol and Ivermectina). Next,
they were conditioned in plastic cages, carpeted with Pinus,
and given purified water from the public water supply and solid
ration (Labina® - Purina Nutrimentos), with a high ad libitum
protein content (20-27%). They were then kept at the bioterium
of the UFRPE at a temperature of 23ºC ± 2ºC in a light-dark-
ness cycle of 12 h at a relative humidity of 70% +/- 5%.
The animals were weighed and submitted to general
anaesthesia. The anaesthetics used were Ketamine (Dopalen -
Vertbrands® / 60-90 mg/kg) and Xilazine (Anasedan -
Vertbrands® / 4-8 mg/kg) in a 1:1 solution in a dose of 0.1 mg/
100g intramuscularly in the left thigh. The animals were con-
sidered anaesthetized when there was no longer any plantar re-
sponse after digital stimulation by the operator.  The surgery
was performed in the following standardized sequence:
1. A linear incision of approximately 15 mm was made
using a #15 blade (tegumentary and subcutaneous planes) on
the dorsal surface of the animal’s right thigh.
2. A blunt dissection was performed using 12-cm
Metzembaum curved scissors to separate the tegumentary and
subcutaneous planes from the lateral and medial surfaces of the
thigh.
3. A blunt dissection was performed using a 12-cm
haemostatic tweezer between the femoral biceps and semiten-
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dinous muscles to view the sciatic nerve.
4. The right sciatic nerve was isolated and subjected
to compression for 2 minutes with a straight 12-cm haemostatic
tweezer. The specific site of compression was the intermediate
region of the sciatic nerve in its course down the thigh before
bifurcating into the tibial and common fibular nerves. The
strength used for compression was standardized at the second
locking position of the haemostatic tweezer (Figure 1).
5. A cutaneous linear suture of the tegumentary and
subcutaneous planes was performed using 5-0 nylon.
FIGURE 1 – Damage to the sciatic nerve by standard compression
The animals used in this research were randomly dis-
tributed in 2 groups – an experimental group (EG) and a con-
trol group (CG), with 48 animals each, divided into 8 subgroups
(EG1, EG2, EG3, EG4; CG1, CG2, CG3 and CG4), with 12
animals each, in accordance with the evaluation periods, and
were assessed postoperatively at 8, 15, 30 and 60 days.
In the animals of the experimental group a ganglio-
side (Sinaxial®-TRB Pharma) was used. The drug was admin-
istered in a dose of 2 mg (0.2 mL) for the attack dose in the first
5 postoperative days and 1 mg (0.1 mL) for the therapeutic dose
in the 5 subsequent days, based on the mean body mass of the
animals, as recommended by the manufacturer, for the 10 days
following the operative act, likewise in accordance with the
manufacturer’s recommendations.  The animals in subgroups
CG1, 2, 3 and 4 were subcutaneously injected with 0.2 mL of
saline solution (Physiologic Serum® - Darrow) in their backs
for five days following surgery and with 0.1 mL of the same
physiologic solution for the subsequent five days, with the aim
of mimicking the volumetric aspects of the injected fluid and
the psychological aspects of the animals in the experimental
subgroups.
For the histopathologic analysis, the surgical speci-
mens from the sciatic nerve were removed with minimum trauma
approximately 10 mm from the site of the trauma and were fixed
in 4% glutaraldehyde, following the sacrifice of the animals.
Next, following immersion in historesin, sections were per-
formed and stained with haematoxilin and eosin (HE), which
allowed the observation of the hyperplasia of the Schwann cells,
Wallerian degeneration, myelin sheath degeneration and for-
mation, endoneural space, nerve regeneration and myelin sheath
density postoperatively at 8, 15, 30 and 60 days.
For the analysis of data the statistical mean and stan-
dard deviation (techniques of descriptive statistics) were ob-
tained using the Student-t tests with equal or unequal variances.
The verification of the hypothesis of equality of variances was
conducted by means of the F test for the specific purpose (tech-
nique of inferential statistics).  The level of significance used in
the results of the statistical tests was 5%. The data were typed
on the Excel spreadsheet and the software used for obtaining of
statistical calculations was the SAS (Statistical Analysis Sys-
tem), version 8.
The present study was submitted to the Ethics in Re-
search Committee of the University of Pernambuco and ap-
proved (120/04) on June 15th, 2004, being in conformity with
good research practices on animals and the Universal Declara-
tion of Animal Rights23.
Results
Descriptive histopathology result
Histopathologically, hyperplasia of the Schwann cells
and Wallerian degeneration were observed in both groups at 8
days. At 15 and 30 days, in the control group the pattern of cell
reaction had decreased, but there were many cells with  cyto-
plasm in activity and cell mitosis; at 60 days, hyperplasia of the
Schwann cells, mitotic activity and nerve regeneration were also
observed (Figure 2).
FIGURE 2 – Photomicrograph of the sciatic nerve
of the rat in cross-section in the control group (origi-
nal magnification 100X.). A: D – Wallerian Degen-
eration / M – Macrophage / S – Schwann Cell / S! –
Schwann Cell forming myelin sheath. B: S – Schwann
Cell / S! – Schwann Cell forming myelin sheath
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At 15 and 30 days, a decrease in the activity of the
Schwann cells was observed in the experimental group, as well
as an apparent improvement in the organization of the nerve
fibres; at 60 days, there were few Schwann cells in the
endoneural space, and the nerve fibres were organized, signal-
ing nerve regeneration (Figure 3).
FIGURE 3 – Photomicrograph of the sciatic nerve of the rat in cross-
section in the experimental group (original magnification 3A-100X,
3B-40X.). A: R – Nerve Regeneration / S – Schwann Cell. B: S – R –
Nerve Regeneration / S – Schwann Cell./ V – Vessel.
Wallerian degeneration, formation of a myelin sheath and oc-
currence of nerve regeneration according to group in the evalu-
ations at 8, 15, 30 and 60 days.
In Table 1 it can be seen that in the evaluation at 8 days
25% of the animals in the experimental group showed moderate
vacuolization, while the remaining 75% possessed intense vacu-
olization. In the control group, moderate vacuolization was not
observed, although 50% of the animals exhibited intense vacu-
olization and the other 50% very intense vacuolization.
At the 15 day evaluation, two thirds (66.7%) of the
animals in the experimental group exhibited slight vacuoliza-
tion, while 25% and 8.3% showed moderate and intense vacu-
olization, respectively. In the control group the corresponding
figures were 36.4%, 36.4% and 27.3%, respectively (Table 2).
At 30 days, in the experimental group 54.6% of the
animals exhibited slight vacuolization and 45.4% intense vacu-
olization. In the control group 36% exhibited slight vacuoliza-
tion, 54.6% moderate vacuolization and 9.1% intense vacuoliza-
tion. At 60 days, all the animals in the experimental group pre-
sented slight vacuolization in the control group; the vacuoliza-
tion was considered slight in 20% of the animals, moderate in
40% and intense in 40%. At different times of evaluation sig-
nificant differences were found between the two groups at a
level of significance of 5.0% (p < 0.05).
TABLE 1 – Evaluation of the vacuolization of Schwann cells and macrophages in control and experimental groups at 8, 15, 30 and 60 days
(*) – Significant difference at 5.0% level.
(1) – Using Fisher’s Exact test.
  Group   
Time (in days) Vacuolization Control Experimental Total  p-Value 
  N % N % n %  
         
  8 Moderate - - 3 25.0 3 12.5 p(1) = 0.0071* 
 Intense   6 50.0 9 75.0 15 62.5  
 Very intense 6 50.0 - - 6 25.0  
         
TOTAL  12 100.0 12 100.0 24 100.0  
         
  15 Slight  - - 8 66.7 8 34.8 p(1) = 0.0017* 
 Moderate 4 36.4 3 25.0 7 30.1  
 Intense   4 36.4 1 8.3 5 21.7  
 Very intense 3 27.3 - - 3 13.0  
         
TOTAL (2)  11 100.0 12 100.0 23 100.0  
(2) – For one animal this information was not available. 
         
  30 Slight  4 36.0 6 54.6 10 45.4 p(1) = 0.0149* 
 Moderate 6 54.6 - - 6 27.3  
 Intense   1 9.1 5 45.4 6 27.3  
         
TOTAL (2)  11 100.0 11 100.0 22 100.0  
(2) – For two animals this information was not available. 
         
  60 Slight  2 20.0 12 100.0 14 63.6 p(1) = 0.0001* 
 Moderate 4 40.0 - - 4 18.2  
 Intense   4 40.0 - - 4 18.2  
         
TOTAL (2)  10 100.0 12 100.0 22 100.0  
(2) – For two animals this information was not available. 
         
Categorized histopathology result
Tables 1 to 4 show the results of the vacuolization in
Schwann cells and macrophages, hyperplasia of Schwann cells,
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In relation to the hyperplasia of the Schwann cells it
can be seen in Table 2 that at 8 days 16.7% of the animals in the
experimental group had slight hyperplasia and 66.7% exhib-
ited intense hyperplasia. In the control group the hyperplasia of
these cells ranged from intense (33.3%) to very intense (66.7%).
At the 15 day evaluation, most of the animals in the
experimental group had slight hyperplasia (83.3%), while 8.3%
had moderate and 8.3% intense hyperplasia. In the control group
moderate hyperplasia was observed in 36.4% of the animals,
intense hyperplasia in 27.3% and very intense hyperplasia in
36.4% (Table 3). At 30 days, in the experimental group 81.8%
of the cases were classified as having slight hyperplasia and the
TABLE 2 – Evaluation of hyperplasia of Schwann cells in control and experimental groups at 8, 15, 30 and 60 days
remaining 18.2% moderate hyperplasia. In the control group,
only 9.1% of the animals had slight hyperplasia. On the other
hand, 72.7% and 18.2% of the animals had moderate and in-
tense hyperplasia, respectively (Table 2).
At 60 days, in the experimental group slight and mod-
erate hyperplasia was observed in 91.7% and 8.3% of the ani-
mals, respectively. In the control group, on the other hand, 40%
of the animals had slight hyperplasia and 60% moderate hyper-
plasia. At the different times of evaluation significant differ-
ences were found between the two groups, with a significance
level of 5.0%, in relation to the categories of hyperplasia of the
Schwann cells (p < 0.05) (Table 2).
(*) – Significant difference at 5.0% level
(1) – Using Fisher’s Exact test
Table 3 shows the results in relation to Wallerian de-
generation. At 8 days, both experimental and control groups
showed intense degeneration. At 15 and 30 days, however, they
exhibited moderate and slight degeneration, respectively. At the
60 day evaluation all the animals in the control group showed a
slight Wallerian degeneration, while in the experimental group
such degeneration was absent and a significant difference was
found for this evaluation (p < 0.05). Comparative statistical tests
were not applied in the evaluations at 8, 15 and 30 days be-
cause all the cases in both groups were classified in a single
category.
  Group   
Time (in days) Hyperplasia of the Control Experimental Total  p-Value 
  Schwann cells N % n % n %  
         
  8 Slight  - - 2 16.7 2 8.3 p(1) = 0.0014* 
 Moderate - - 2 16.7 2 8.3  
 Intense   4 33.3 8 66.7 12 50.0  
 Very intense 8 66.7 - - 8 33.3  
         
TOTAL  12 100.0 12 100.0 24 100.0  
         
  15 Slight  - - 10 83.3 10 43.5 p(1) < 0.0001* 
 Moderate 4 36.4 1 8.3 5 21.7  
 Intense   3 27.3 1 8.3 4 17.4  
 Very intense 4 36.4 - - 4 17.4  
         
TOTAL (2)  11 100.0 12 100.0 23 100.0  
(2) – For one animal this information was not available. 
         
  30 Slight  1 9.1 9 81.8 10 45.6 p(1) = 0.0032* 
 Moderate 8 72.7 2 18.2 10 45.6  
 Intense 2 18.2 - - 2 9.1  
         
TOTAL (2)  11 100.0 11 100.0 22 100.0  
(2) – For two animals this information was not available. 
         
  60 Slight  4 40.0 11 91.7 15 68.2 p(1) = 0.0201* 
 Moderate 6 60.0 1 8.3 7 31.8  
         
TOTAL (2)  10 100.0 12 100.0 22 100.0  
(2) – For two animals this information was not available. 
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TABLE 3 – Evaluation of Wallerian degeneration in control and experimental groups at 8, 15, 30 and 60 days
(*) – Significant difference at 5.0% level
(1) – Using Fisher’s Exact Test
Concerning the formation of the myelin sheath, it was
seen that at 8 days neither group showed evidence of restruc-
turing of this component of the nervous fibre. In the evaluation
at 15 days, 100% of the animals the control group had only a
TABLE 4 – Evaluation of myelin sheath formation in control and experimental groups at 8, 15, 30 and 60 days
(*) – Significant difference at 5.0% level
(1) – Using Fisher’s Exact test
weakly present myelin sheath. In the experimental group, the
myelin sheath was only weakly present in 33.3%, while it was
moderately present in 41.7% and strongly present in 25% (Table 4).
  Group   
Time (in days) Myelin sheath  Control Experimental Total  p Value 
 formation n % n % n %  
         
  8 Absent  12 100.0 12 100.0 24 100.0 ** 
         
TOTAL  12 100.0 12 100.0 24 100.0  
         
  15 Weak presence 11 100.0 4 33.3 15 65.2 p(1) = 0.0013* 
 Moderate presence - - 5 41.7 5 21.7  
 Strong presence - - 3 25.0 3 13.0  
         
TOTAL (2)  11 100.0 12 100.0 23 100.0  
(2) – For one animal this information was not available. 
         
  30 Weak presence 11 100.0 - - 11 50.0 p(1) < 0.0001* 
 Strong presence - - 11 100.0 11 50.0  
         
TOTAL (2)  11 100. 11 100.0 22 100.0  
(2) – For two animals this information was not available. 
         
  60 Weak presence 6 60.0 - - 6 27.3 p(1) < 0.0001* 
 Moderate presence 4 40.0 - - 4 18.2  
 Strong presence - - 12 100.0 12 54.5  
         
TOTAL (2)  10 100.0 12 100.0 22 100.0  
(2) – For two animals this information was not available. 
         
  Group   
Time (in days) Wallerian Control Experimental Total  p Value 
 degeneration n % N % n %  
         
  8 Intense  12 100.0 12 100.0 24 100.0 ** 
         
TOTAL  12 100.0 12 100.0 24 100.0  
         
  15 Moderate  11 100.0 12 100.0 23 100.0 ** 
         
TOTAL (2)  11 100.0 12 100.0 23 100.0  
(2) – For one animal this information was not available. 
         
  30 Slight 11 100.0 11 100.0 22 100.0 ** 
         
TOTAL (2)  11 100.0 11 100.0 22 100.0  
(2) – For two animals this information was not available. 
         
  60 Absent - - 12 100.0 12 54.6 p(1) < 0.0001*  
 Slight  10 100.0 - - 10 45.4  
         
TOTAL (2)  10 100.0 12 100.0 22 100.0  
(2) – For two animals this information was not available. 
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At 30 days, the animals in the control group had 100%
of their fibres with the myelin sheath only weakly present, while
in the experimental group it was strongly present in the nerve
fibres of 100% of the animals (Table 4). At 60 days, in 100% of
the animals in the experimental group the myelin sheath was
strongly present. In the control group it was only weakly present
in 60% of the animals and moderately present in 40%. Signifi-
cant differences were recorded between the two groups at the
15, 30 and 60 day evaluations (p < 0.05).
Nerve regeneration was shown to be absent in the two
groups at the 8 and 15 day evaluations. At 30 days, it was found
that the animals in the control group displayed no nerve regen-
eration. On the other hand, 100% of the animals in the experi-
mental group showed moderate regeneration. At 60 days, in the
control group 100% of the animals showed moderate nerve re-
generation, while in the experimental group intense nerve re-
generation was found in 100%. Significant differences were
observed (p < 0.05) between the groups at the 30 and 60 days
evaluations (Table 4).
Discussion
The experimental model adopted in this study was
based on an intentional injury to a mixed peripheral nerve for
the purpose of causing the total disruption of nerve conduction
towards the effector organ. The choice of the sciatic nerve of
mice not only met the specified requirements, but was also found
to be well established in the literature consulted2,4,5,6,7,8. The
choice of this experimental model was also favoured by the
diameter of the sciatic nerve and by its relatively easy surgical
access on the posterior surface of the thigh of the animal in
question10,11. In our study, after specific technical training, the
surgical technique for producing the nerve injury was shown to
be feasible and was compatible with the duration of the general
anaesthesia.
Peripheral nerve compression represents an experiment
delineated with the intention of minimizing interference from
local agents. This is corroborated by the fact that it maintains
the integrity of most of the basal laminae of the endoneural
tubes, thus isolating the content of the tubes in relation to the
adjacent tissues, thereby minimizing the effect of biological
barriers, which might jeopardize the natural course of axonal
growth towards the target organs6. The choice of the methodol-
ogy was also based on studies12,13 which reported that the most
frequent lesions in sciatic nerves of humans are due to
neurapraxia or axonotmesis.
Tos et al.16 described the proliferation of Schwann cells,
the presence of active macrophages and the fragmentation of
the distal segment of the axon, together with the myelin sheath,
as peculiar characteristics of nerve injury. Our studies corrobo-
rate such physiologic phenomena, for the descriptive histopa-
thology findings at 8 days for both experimental and control
groups demonstrated the occurrence of a cellular pattern with
the presence of macrophages and Schwann cells with active
cytoplasms (vacuolization), a cellular pattern that had receded
at the 15, 30 and 60 day evaluations. Tos et al.16 also reported
that Schwann cells produce a series of molecules with neu-
rotrophic activity, such as growth factors derived from glia and
the brain (NGF and BDNF), and especially growth factors as-
sociated with the extracellular matrix, such as the proteoglican-
laminine complex. In our study, there was a significant differ-
ence between the groups for the proliferation of Schwann cells
at 8 days and for regeneration at 30 and 60 days, which sug-
gests neurotrophic activity on the part of the Schwann cells.
Our results corroborate those of Langone and Silva19
in that we found significant differences between the experimen-
tal and control groups, which was indicative of the action of the
gangliosides as a drug able to stimulate axonal growth and the
maturation of nerve fibres in regeneration. However, Langone
and Silva19 studied the local action of the GM1, GD1a, GD1b
and GT1b gangliosides, while our study was based on their sys-
temic action through the subcutaneous route of administration.
On the basis of our set of results, there is evidence that the route
of administration did not interfere with the combined action of
the gangliosides studied.
Other studies9,20,21 have suggested that the action of
the ganglioside GM1 produces a slight increase in peripheral
nerve regeneration. Our results were based on the use of a com-
bination of the gangliosides GM1, GD1a, GD1b and GT1b, but
we obtained significant findings for several parameters, such
as Schwann cells, macrophages, myelin sheath, regeneration,
myelin density and ischiatic functional index.
Our results suggest that the action of the gangliosides
was proliferative for Schwann cells at 8 days and inhibitory for
inflammatory cells at 8 and 15 days. These results are in partial
disagreement with other studies9, 18, in which the experiments
covered periods of more than 45 days. At 60 days, our results
were no longer significant for Schwann cells or macrophages;
however, we found a larger quantity of mature nerve fibres in
the experimental group than in the control group which, for its
part, contained a greater density of myelin in the process of
formation. In our opinion, factors such as the evaluation pe-
riod, study of the nerve longitudinally rather than in cross-sec-
tion and the immersion of the nerve segment in paraffin instead
of historesin, may have affected the results of the
abovementioned authors.
On the basis of the results obtained and the literature
consulted9,18,19,20,21, we suggest that further studies be conduced
with a view to deepening our understanding of the action of the
gangliosides in peripheral nerve regeneration, bearing in mind
the gaps in our knowledge that still exist regarding this ques-
tion. To this end, we suggest an investigation of the action of
gangliosides over periods of less than 8 days and greater than
60 days, a comparison of the use of Gm1 with the combination
of GM1, GD1a, GD1b and GT1b, haematological studies for
the characterization of a possible modulating action of the im-
mune system, pharmacological studies with the aim of observ-
ing a possible modulating action of inflammation, and a toxico-
logical study for the purpose of establishing safe doses for time
periods greater than 15 days.
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Conclusion
The administration of exogenous gangliosides seems
to increase nerve regeneration, for it stimulated the prolifera-
tion of the Schwann cells and reduced the presence of inflam-
matory ones, thereby promoting nerve regeneration after
axonotmesis.
References
1. Vasconcelos BC, Gay Escoda C, Vasconcellos RJ, Neves RF. Con-
duction velocity of the rabbit facial nerve: a noninvasive functional
evaluation. Pesqui Odontol Bras. 2003;17:126-31.
2. De Medinacelli L, Freed WJ, Wyatt RJ. An index of the functional
condition of rat sciatic nerve based on measurements made from walk-
ing tracks. Exp Neur. 1982;77:6634-43.
3. Nachemson AK, Lundborg G, Myrhage R, Rank F. Nerve regenera-
tion and pharmacological suppression of the scar reaction at the suture
site. Scand J Plast Reconstr Surg. 1985;19:255-60.
4. Danielsen N, Varon S. Characterization of neurotrophic activity in
the silicone chamber model for nerve regeneration. J Reconstr
Microsurg. 1995;11:231-5.
5. Catan FG, Pastorello A, Siliprandi R, Savastano M, Molinari G. Brain
cortex gangliosides and Na+, K+)-ATPase system of the stria vascularis
in the guinea pig. Acta Otolaryngol. 1981;92:433-7.
6. Cunha MTR, Silva AR, Fenelon SB. Comparision of nerve integra-
tion after segmentar resection versus epineural burying in crushed rat
sciatic nerves. Acta Cir Bras. 1997;4:221-5.
7. Chen ZY, Chai YF, Cao L, Lu CL, He C. Glial cell line-derived
neurotrophic factor enhances axonal regeneration following sciatic
nerve transection in adult rats. Brain Res. 2001;2:272-6.
8. Abreu AAN, Wei TH, Zumiotti AV. Avaliação dos gangliosídeos na
regeneração nervosa em ratos. Rev Bras Ortop. 2002;37:39-44.
9. Neto JC, Vasconcelos BC, Sobral AP, da Silva VA Jr, Nogueira RV.
Clinical and histopathologic study of the use of gangliosides for nerve
regeneration in rats after axonotmesis. J Oral Maxillofac Surg.
2007;65:870-4.
10. de Ruiter GC, Spinner RJ, Alaid AO, Koch AJ, Wang H, Malessy
MJ, Currier BL, Yaszemski MJ, Kaufman KR, Windebank AJ. Two-
dimensional digital video ankle motion analysis for assessment of func-
tion in the rat sciatic nerve model. J Peripher Nerv Syst. 2007;12:216-
22.
11. Schmalbruch H. Fiber composition of the sciatic nerve. Anat Rec.
1986;215(1):71-81.
12. Apley AG. Teaching techniques and training methods in ortho-
paedics. Proc R Soc Med. 1966;59(2):117.
13. Kline DG, Kim D, Midha R, Harsh C, Tiel R. Management and
results of sciatic nerve injuries: a 24-year experience. J Neurosurg.
1998;89:13-23.
14 Gomes AC, Vasconcelos BC, de Oliveira e Silva ED, da Silva LC.
Lingual nerve damage after mandibular third molar surgery: a ran-
domized clinical trial. J Oral Maxillofac Surg. 2005;63:1443-6.
15. Horch HW, Krüttgen A, Portbury SD, Katz LC. Destabilization of
cortical dendrites and spines by BDNF. Neuron. 1999;23(2):353-64.
16. Tos P, Ronchi G, Nicolino S, Audisio C, Raimondo S, Fornaro M,
Battiston B, Graziani A, Perroteau I, Geuna S. Employment of the
mouse median nerve model for the experimental assessment of pe-
ripheral nerve regeneration. J Neurosci Methods. 2008;169(1):119-27.
17. Graff-Radford SB, Evans RW. Lingual nerve injury. Headache.
2003;43:975-83.
18. Montovani JC, Prado RG, Bacchi CE. Experimental surgery of the
facial nerve: Evaluation of the intraperitoneal use of exogenous gan-
gliosides. Rev Laryngol Otol Rhinol. 1995;116:163-7.
19. Langone F, Silva CF. Exogenous ganglioside stimulation of ax-
onal regeneration after new transsection and intubation repair. Braz J
Med Biol. 1990;23:823-6.
20. Lainetti RD, Silva CF. Local addition of monosialoganglioside
GM1 stimulates peripheral axon regeneration in vivo. Braz J Med Biol
Res. 1993;26:841-5.
21. Sobeski JK, Kerns JM, Safanda JF, Shott S, Gonzalez MH. Func-
tional and structural effects of GM-1 ganglioside treatment on periph-
eral nerve grafting in the rat. Microsurgery. 2001;21:108-15.
22. Amico-Roxas M, Caruso A, Trombadore S, Scifo R, Scapagnini
U. Gangliosides antinociceptive effects in rodents. Arch Int
Pharmacodyn Ther. 1984;272(1):103-17.
23. UNESCO. United Nations Educational, Scientific and Culture
Organization. Universal Declaration of Animal Rights. 1978: Bruxelles.
Available from URL: http://portal.unesco.org/en/ev.php-
URL_ID=29008&URL_DO=DO_TOPIC&URL_SECTION=201.html
Conflict of interest: none
Financial source: CNPq/PIBIC
How to cite this article
Ribeiro CMB, Vasconcelos BCE, Silva Neto JC, Silva JR VA, Figueiredo NG. Histopathological analysis of gangliosides use in
peripheral nerve regeneration after axonotmesis in rats. Acta Cir Bras. [serial on the Internet] 2008 July-Aug;23(4). Available
from URL: http://www.scielo.br/acb
Correspondence:
Prof. Dr. Belmiro Cavalcanti do Egito Vasconcelos
Av. Gal. Newton Cavalcanti, 1650
54753-220  Camaragibe – PE  Brazil
Phone: (55 81)3458-2867
belmiro@pq.cnpq.br
Received: January 15, 2008
Review: February 12, 2008
Accepted: April 18, 2008
*Color figures available from www.scielo.br/acb
